Susceptibility of outer hair cells to cholesterol chelator 2-hydroxypropyl-β-cyclodextrine is prestin-dependent

Sci Rep. 2016 Feb 23:6:21973. doi: 10.1038/srep21973.

Abstract

Niemann-Pick type C1 disease (NPC1) is a fatal genetic disorder caused by impaired intracellular cholesterol trafficking. Recent studies reported ototoxicity of 2-hydroxypropyl- β-cyclodextrin (HPβCD), a cholesterol chelator and the only promising treatment for NPC1. Because outer hair cells (OHCs) are the only cochlear cells affected by HPβCD, we investigated whether prestin, an OHC-specific motor protein, might be involved. Single, high-dose administration of HPβCD resulted in OHC death in prestin wildtype (WT) mice whereas OHCs were largely spared in prestin knockout (KO) mice in the basal region, implicating prestin's involvement in ototoxicity of HPβCD. We found that prestin can interact with cholesterol in vitro, suggesting that HPβCD-induced ototoxicity may involve disruption of this interaction. Time-lapse analysis revealed that OHCs isolated from WT animals rapidly deteriorated upon HPβCD treatment while those from prestin-KOs tolerated the same regimen. These results suggest that a prestin-dependent mechanism contributes to HPβCD ototoxicity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Brain / pathology
  • Cell Death / drug effects
  • Chelating Agents / administration & dosage
  • Chelating Agents / adverse effects*
  • Cholesterol / metabolism
  • Disease Susceptibility
  • Gene Expression
  • Hair Cells, Auditory, Outer / drug effects*
  • Hair Cells, Auditory, Outer / metabolism
  • Hair Cells, Auditory, Outer / pathology
  • Hearing Loss, Sensorineural / chemically induced
  • Hearing Loss, Sensorineural / genetics*
  • Hearing Loss, Sensorineural / pathology
  • Humans
  • Mice
  • Mice, Knockout
  • Molecular Motor Proteins / deficiency
  • Molecular Motor Proteins / genetics*
  • Neuroprotective Agents / administration & dosage
  • Neuroprotective Agents / adverse effects*
  • Niemann-Pick Disease, Type C / drug therapy
  • Niemann-Pick Disease, Type C / genetics
  • Niemann-Pick Disease, Type C / metabolism
  • Niemann-Pick Disease, Type C / pathology
  • Time-Lapse Imaging
  • beta-Cyclodextrins / administration & dosage
  • beta-Cyclodextrins / adverse effects*

Substances

  • Chelating Agents
  • Molecular Motor Proteins
  • Neuroprotective Agents
  • Pres protein, mouse
  • beta-Cyclodextrins
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Cholesterol